Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Proteomics identifies neddylation as a potential therapy target in small intestinal neuroendocrine tumors.

Fotouhi O, Kjellin H, Juhlin CC, Pan Y, Vesterlund M, Ghaderi M, Yousef A, Andersson-Sand H, Kharaziha P, Caramuta S, Kjellman M, Zedenius J, Larsson C, Orre LM.

Oncogene. 2019 Oct;38(43):6881-6897. doi: 10.1038/s41388-019-0938-8. Epub 2019 Aug 12.

PMID:
31406256
2.

Telomerase activation in small intestinal neuroendocrine tumours is associated with aberrant TERT promoter methylation, but not hot-spot mutations.

Fotouhi O, Ghaderi M, Wang N, Zedenius J, Kjellman M, Xu D, Juhlin CC, Larsson C.

Epigenetics. 2019 Dec;14(12):1224-1233. doi: 10.1080/15592294.2019.1634987. Epub 2019 Jul 19.

PMID:
31322481
3.

Operating hurts: a study of EAES surgeons.

Wells AC, Kjellman M, Harper SJF, Forsman M, Hallbeck MS.

Surg Endosc. 2019 Mar;33(3):933-940. doi: 10.1007/s00464-018-6574-5. Epub 2018 Nov 19.

4.

Treatment and outcomes in pheochromocytomas and paragangliomas: a study of 110 cases from a single center.

Falhammar H, Kjellman M, Calissendorff J.

Endocrine. 2018 Dec;62(3):566-575. doi: 10.1007/s12020-018-1734-x. Epub 2018 Sep 15.

5.

Somatostatin Receptor Expression in Renal Cell Carcinoma-A New Front in the Diagnostics and Treatment of Renal Cell Carcinoma.

Höög A, Kjellman M, Mattsson P, Juhlin CC, Shabo I.

Clin Genitourin Cancer. 2018 Jun;16(3):e517-e520. doi: 10.1016/j.clgc.2018.03.011. Epub 2018 Mar 27. No abstract available.

PMID:
29656940
6.

Initial clinical presentation and spectrum of pheochromocytoma: a study of 94 cases from a single center.

Falhammar H, Kjellman M, Calissendorff J.

Endocr Connect. 2018 Jan;7(1):186-192. doi: 10.1530/EC-17-0321. Epub 2017 Dec 7.

7.

Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center.

Patrova J, Kjellman M, Wahrenberg H, Falhammar H.

Endocrine. 2017 Nov;58(2):267-275. doi: 10.1007/s12020-017-1400-8. Epub 2017 Sep 8.

PMID:
28887710
8.

Intraoperative workload in robotic surgery assessed by wearable motion tracking sensors and questionnaires.

Yu D, Dural C, Morrow MM, Yang L, Collins JW, Hallbeck S, Kjellman M, Forsman M.

Surg Endosc. 2017 Feb;31(2):877-886. doi: 10.1007/s00464-016-5047-y. Epub 2016 Aug 5.

PMID:
27495330
9.

Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors.

Fotouhi O, Kjellin H, Larsson C, Hashemi J, Barriuso J, Juhlin CC, Lu M, Höög A, Pastrián LG, Lamarca A, Soto VH, Zedenius J, Mendiola M, Lehtiö J, Kjellman M.

J Clin Endocrinol Metab. 2016 Oct;101(10):3616-3627. Epub 2016 Jul 26.

10.

Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: an in vivo and in vitro study.

Fotouhi O, Adel Fahmideh M, Kjellman M, Sulaiman L, Höög A, Zedenius J, Hashemi J, Larsson C.

Epigenetics. 2014 Jul;9(7):987-97. doi: 10.4161/epi.28936. Epub 2014 Apr 24.

11.

Differentially expressed proteins in malignant and benign adrenocortical tumors.

Kjellin H, Johansson H, Höög A, Lehtiö J, Jakobsson PJ, Kjellman M.

PLoS One. 2014 Feb 3;9(2):e87951. doi: 10.1371/journal.pone.0087951. eCollection 2014.

12.

Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization.

Hashemi J, Fotouhi O, Sulaiman L, Kjellman M, Höög A, Zedenius J, Larsson C.

BMC Cancer. 2013 Oct 29;13:505. doi: 10.1186/1471-2407-13-505.

13.

Utilization of a non-preserved cadaver to address deficiencies in technical skills during the third year of medical school.

Kjellman M.

World J Surg. 2013 May;37(5):956. doi: 10.1007/s00268-013-1929-5. No abstract available.

PMID:
23474854
14.

ProMIS™ can serve as a da Vinci® simulator--a construct validity study.

Jonsson MN, Mahmood M, Askerud T, Hellborg H, Ramel S, Wiklund NP, Kjellman M, Ahlberg G.

J Endourol. 2011 Feb;25(2):345-50. doi: 10.1089/end.2010.0220. Epub 2010 Nov 29.

PMID:
21114413
15.

Preoperative 99Tc(m)-sestamibi scintigraphy with SPECT localizes most pathologic parathyroid glands.

Lindqvist V, Jacobsson H, Chandanos E, Bäckdahl M, Kjellman M, Wallin G.

Langenbecks Arch Surg. 2009 Sep;394(5):811-5. doi: 10.1007/s00423-009-0536-2. Epub 2009 Jul 4.

PMID:
19578871
16.

Transcriptional profiling enables molecular classification of adrenocortical tumours.

Laurell C, Velázquez-Fernández D, Lindsten K, Juhlin C, Enberg U, Geli J, Höög A, Kjellman M, Lundeberg J, Hamberger B, Larsson C, Nilsson P, Bäckdahl M.

Eur J Endocrinol. 2009 Jul;161(1):141-52. doi: 10.1530/EJE-09-0068. Epub 2009 May 1.

PMID:
19411298
17.

Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy.

Velázquez-Fernández D, Laurell C, Geli J, Höög A, Odeberg J, Kjellman M, Lundeberg J, Hamberger B, Nilsson P, Bäckdahl M.

Surgery. 2005 Dec;138(6):1087-94.

PMID:
16360395
18.

Aberrations of centrosomes in adrenocortical tumors.

Roshani L, Fujioka K, Auer G, Kjellman M, Lagercrantz S, Larsson C.

Int J Oncol. 2002 Jun;20(6):1161-5.

PMID:
12011993
19.

Alterations of the SDHD gene locus in midgut carcinoids, Merkel cell carcinomas, pheochromocytomas, and abdominal paragangliomas.

Kytölä S, Nord B, Elder EE, Carling T, Kjellman M, Cedermark B, Juhlin C, Höög A, Isola J, Larsson C.

Genes Chromosomes Cancer. 2002 Jul;34(3):325-32.

PMID:
12007193

Supplemental Content

Loading ...
Support Center